Invesco’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.5M Buy
857,980
+126,404
+17% +$2.73M ﹤0.01% 1477
2025
Q1
$12.2M Buy
731,576
+219,256
+43% +$3.64M ﹤0.01% 1695
2024
Q4
$9.4M Sell
512,320
-45,744
-8% -$839K ﹤0.01% 1895
2024
Q3
$8.58M Buy
558,064
+472,640
+553% +$7.27M ﹤0.01% 1920
2024
Q2
$1.39M Sell
85,424
-264,963
-76% -$4.31M ﹤0.01% 2769
2024
Q1
$6.48M Sell
350,387
-72,582
-17% -$1.34M ﹤0.01% 2065
2023
Q4
$13.2M Buy
422,969
+89,997
+27% +$2.82M ﹤0.01% 1639
2023
Q3
$6.94M Sell
332,972
-64,548
-16% -$1.35M ﹤0.01% 2004
2023
Q2
$9.52M Sell
397,520
-76,450
-16% -$1.83M ﹤0.01% 1844
2023
Q1
$8.92M Sell
473,970
-61,774
-12% -$1.16M ﹤0.01% 1885
2022
Q4
$8.53M Buy
535,744
+54,824
+11% +$873K ﹤0.01% 1952
2022
Q3
$7.87M Buy
480,920
+31,226
+7% +$511K ﹤0.01% 1945
2022
Q2
$6.34M Sell
449,694
-26,172
-5% -$369K ﹤0.01% 2148
2022
Q1
$11.5M Buy
475,866
+409,120
+613% +$9.91M ﹤0.01% 1882
2021
Q4
$1.56M Sell
66,746
-4,796
-7% -$112K ﹤0.01% 2875
2021
Q3
$1.19M Buy
71,542
+8,626
+14% +$143K ﹤0.01% 3008
2021
Q2
$1.54M Sell
62,916
-4,525
-7% -$110K ﹤0.01% 2929
2021
Q1
$1.74M Sell
67,441
-1,125,174
-94% -$29M ﹤0.01% 2822
2020
Q4
$63.8M Buy
1,192,615
+891,392
+296% +$47.7M 0.02% 942
2020
Q3
$12.4M Sell
301,223
-3,871
-1% -$160K ﹤0.01% 1548
2020
Q2
$14.8M Sell
305,094
-268,532
-47% -$13M 0.01% 1418
2020
Q1
$24.2M Sell
573,626
-950,634
-62% -$40.2M 0.01% 1120
2019
Q4
$65.2M Sell
1,524,260
-2,587,265
-63% -$111M 0.02% 875
2019
Q3
$148M Buy
4,111,525
+96,043
+2% +$3.46M 0.04% 519
2019
Q2
$107M Buy
4,015,482
+3,633,171
+950% +$97.1M 0.03% 652
2019
Q1
$10.3M Sell
382,311
-129,476
-25% -$3.48M ﹤0.01% 1553
2018
Q4
$8.28M Sell
511,787
-3,377
-0.7% -$54.6K ﹤0.01% 1633
2018
Q3
$10.7M Buy
515,164
+219,261
+74% +$4.55M ﹤0.01% 1656
2018
Q2
$4.52M Sell
295,903
-6,335
-2% -$96.7K ﹤0.01% 2201
2018
Q1
$6.79M Sell
302,238
-1,467,176
-83% -$33M ﹤0.01% 1771
2017
Q4
$53.3M Sell
1,769,414
-224,853
-11% -$6.77M 0.02% 745
2017
Q3
$75.1M Buy
1,994,267
+608
+0% +$22.9K 0.03% 603
2017
Q2
$55.6M Buy
1,993,659
+346,706
+21% +$9.67M 0.02% 727
2017
Q1
$56.6M Buy
1,646,953
+479,003
+41% +$16.5M 0.02% 729
2016
Q4
$33.7M Buy
1,167,950
+4,080
+0.4% +$118K 0.01% 967
2016
Q3
$37M Buy
1,163,870
+10,603
+0.9% +$337K 0.01% 911
2016
Q2
$37.4M Buy
1,153,267
+2,824
+0.2% +$91.7K 0.01% 890
2016
Q1
$32.2M Sell
1,150,443
-116,152
-9% -$3.25M 0.01% 940
2015
Q4
$45.2M Buy
1,266,595
+22,070
+2% +$787K 0.02% 804
2015
Q3
$41.2M Sell
1,244,525
-88,411
-7% -$2.92M 0.02% 831
2015
Q2
$55.8M Buy
1,332,936
+861,555
+183% +$36.1M 0.02% 757
2015
Q1
$15.4M Buy
471,381
+13,851
+3% +$451K 0.01% 1337
2014
Q4
$14.5M Hold
457,530
0.01% 1346
2014
Q3
$11.3M Hold
457,530
﹤0.01% 1480
2014
Q2
$10.3M Sell
457,530
-717,536
-61% -$16.2M ﹤0.01% 1540
2014
Q1
$28.6M Buy
1,175,066
+734,723
+167% +$17.9M 0.01% 1051
2013
Q4
$11M Sell
440,343
-463,802
-51% -$11.6M ﹤0.01% 1483
2013
Q3
$24.8M Buy
904,145
+343,333
+61% +$9.43M 0.01% 1065
2013
Q2
$10.2M Buy
+560,812
New +$10.2M ﹤0.01% 1409